precipitation and neutralization tests. Fourteen MAbs directed against the NY-1 strain recognized the gp48 and showed a weak neutralizing activity in the presence of goat anti-mouse immunoglobulin serum.
Bovine viral diarrhoea virus (BVDV), a member of the pestivirus genus, is an important pathogen of cattle and is responsible for bovine viral diarrhoea and mucosal disease. BVDV is antigenically closely related to the other two members of this genus, border disease virus (BDV) of sheep and hog cholera virus (HCV).
The virion envelope is thought to contain two major glycoproteins (gp48 and gp53) (Donis et al., 1988) . A 116K precursor may be cleaved into gp53 and gp62, and gp62 subsequently would be processed to give gp48 and gp25 (Collett et al., 1988) . Neutralizing monoclonal antibodies (MAbs) directed against gp53 have been described by several authors (Magar et al., 1988 ; Bolin et al., 1988; Donis et al., 1988; Weiland et al., 1989) . This glycoprotein was therefore thought to be involved in attachment and/or penetration of the virus into host cells (Donis et al., 1988) but there are still no experimental data available to support this hypothesis. Likewise, no study on the function of gp48 has yet been carried out. The aim of this work was to produce MAbs against BVDV and to study their neutralizing activity in order to understand the role of both major glycoproteins in the interactions of the virus with host cells.
Bovine testicular cells (BTC) were infected with the cytopathic biotype of the Osloss (OS-c) strain and with the non-cytopathic NY-1 strain. After 4 days, the cells were frozen and thawed once. Samples of the viral suspension (500 gl; approximately 105 TCIDs0/ml for OS-c and 106 TCIDso/ml for NY-1) were injected twice intraperitoneally 3 weeks apart (in 500 gl complete Freund's adjuvant and incomplete Freund's adjuvant, respectively) and once more intravenously 4 days before fusion. Splenocytes and Sp2/0 myeloma cells were fused with polyethylene glycol 4000 according to the method of K6hler & Milstein (1975) modified by Thiriart et al. (1987) . Screening of hybrids was performed by an indirect immunofluorescence assay (IFA) as described by Mignon et al. (1990) . Hybridomas secreting specific antibodies to BVDV were subcloned three times in agarose (Sigma). lsotypes were determined by double immunodiffusion with anti-mouse subclass antibodies (Meloy Laboratories and Sigma).
Sixteen hybridomas were produced against the NY-1 BVDV strain (referred to as NY-1 to NY-16) and five against the OS-c strain (OS-c 21 to OS-c 25). All of these MAbs were IgG1 except MAb NY-9 (IgG2a).
In order to determine their protein specificity, MAbs were tested by radioimmunoprecipitation assay (RIPA). BTC grown in 80 cm 2 or 25 cm 2 flasks (Nunc) were infected with the OS-c strain at an m.o.i. > 2.5. Mockinfected labelled BTC were used as a control. Thirteen hours after infection, cells were washed and incubated with methionine-free MEM (Gibco) ready for labelling with [35S]methionine. One hour later, 50 gCi/ml of [35S]methionine (Amersham) or 125 gCi/ml of [3H]-glucosamine was added. The supernatant was discarded 8 h later, and the cells were lysed in a buffer containing 0.15 M-NaC1, 0.05 M-Tris-HC1 pH 7.2, 1% Triton X-100, 0.1% NaN3 and 0.1 mM-PMSF (buffer I). The suspension was then clarified for 15 min at 12 700 g and the supernatant was used in the RIPAs. For [3H]glucosamine labelling, the viral suspension was harvested when 90% of the monolayer was lysed and added with 2% Triton X-100 and 0.1 mM-PMSF. Protein A-Sepharose CL-4B (75 lal) (Pharmacia) at 10% in 0.1 M-sodium phosphate buffer pH 8.1 was incubated with 20 gl of 0000-9692 © 1991 SGM rabbit anti-mouse Ig serum (Dakopatts) for 30 min at room temperature. After two washes, 1 ml of hybridoma culture supernatant was added for 1 h at 4 °C. The beads were then washed twice and saturated overnight with 100 ~tl of non-infected and non-labelled cell lysate at 4 °C. Labelled cell lysate (50 ~1), adsorbed for one night on an equal volume of Staphylococcus aureus cells (Calbiochem), was added and incubated for 2 h at 4 °C. After five washings in buffer I and two in buffer II (0.05 M-Tris-HC1 pH 7.2, 0.05 M-NaCI), the immune complexes were dissociated in 50 91 of electrophoresis buffer: boiled for 3 rain and subjected to electrophoresis according to Laemmli (1970) . The five MAbs produced against the OS-c strain precipitated the non-structural 80K protein and its 120K precursor. Two anti-NY-1 MAbs were directed against gp53 (Fig. 1, lane 2) whereas the other 14 MAbs precipitated gp48 (the Mr of which was estimated at 45K for the OS-c strain) and also gp53 and a 62K protein (Fig.  1, lane 1) . Coprecipitation of gp53 by anti-gp48 MAbs has already been described by Donis et al. (1988) . The 62K protein could be the precursor of the gp48 described by Collett et al. (1988) . Nevertheless, this protein was also coprecipitated by anti-gp53 MAbs (Fig. 1, lane 2) .
Mabs were further characterized by testing them against a panel of pestivirus strains (Fig. 2) Bovine and ovine strains were tested by IFA whereas porcine strains, produced on PK-15 cells, were tested by an indirect immunoperoxidase assay as described by Greiser-Wilke et al. (1990) . Anti-gp53 MAbs showed the broadest spectrum of reactivity against bovine strains but a very weak reactivity with ovine and porcine strains whereas some anti-gp48 MAbs reacted with epitopes which were very well conserved between the three pestiviruses.
All the anti-BVDV neutralizing MAbs described so far have been directed against the 53K glycoprotein ( Donis et al., 1988; Magar et al., 1988; Bolin et al., 1988 ; Weiland et al., 1989) . In order to determine whether other proteins could also be involved in the inhibition of virus infectivity, neutralization tests were performed with all of our MAbs. Wells containing 50 ~1 of the OS-c strain at a TCIDs0 of 50 were mixed in duplicate with an equal volume of ascitic fluids which were partially purified by ammonium sulphate precipitation and diluted to obtain 1 mg/ml of Ig. The biological activity of MAbs was conserved after this treatment as determined by titration by IFA. The virus-MAb mixtures were incubated for 2 h at 37 °C. At this time, 5 x 104 M D B K cells in MEM containing 4% horse serum were added per well [in order to facilitate attachment of cells in such a medium, the plates had been coated with attachment factors (Vitrogen-100, Flow Laboratories)]. After 1 week at 37 °C, the cells were fixed and stained with a wateralcohol solution of crystal violet. The same test was also performed with the addition of 50 ~1 of goat anti-mouse Ig serum diluted fivefold in MEM. This serum was checked for the absence of pestivirus antigen or antibody. Its titre determined by a double immunodiffusion test was 16. In the absence of goat serum, only antigp53 MAbs showed neutralizing activity but when goat serum was added two anti-gp48 MAbs (NY-5 and NY-11) became neutralizing and the neutralizing titre of the anti-gp53 NY-9 MAb was enhanced ( Table 1 ). The latter * Neutralizing titres against 50 TCID~0 of the OS-c strain were expressed as the inverse of the last dilution of MAb that showed complete inhibition of the c.p.e. humoral defence mechanism. Wensvoort (1989) also described three neutralizing MAbs directed against gp42 of HCV, equivalent to the gp48 of BVDV, which were characterized by lower neutralizing titres than those of anti-El MAbs. The fact that neutralizing titres of MAbs were enhanced in the presence of goat anti-mouse Ig serum would suggest that the MAbs are not directed against critical neutralizing sites and that goat Igs could cause steric hindrance, hiding a functional domain of the protein.
These MAbs could be useful tools to study the mechanisms of BVDV neutralization and to assess the functions of gp53 and gp48.
Addendum. While the present manuscript was being reviewed a paper reporting similar findings by Xue et al. (1990) has appeared.
